Jin Medical International (ZJYL) Equity Ratio (2022 - 2025)
Jin Medical International's Equity Ratio history spans 3 years, with the latest figure at 0.06 for Q3 2024.
- For Q3 2024, Equity Ratio fell 91.97% year-over-year to 0.06; the TTM value through Sep 2024 reached 0.06, down 91.97%, while the annual FY2024 figure was 0.06, 91.97% down from the prior year.
- Equity Ratio for Q3 2024 was 0.06 at Jin Medical International, down from 0.73 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.73 in Q3 2023 and bottomed at 0.06 in Q3 2024.
- The 3-year median for Equity Ratio is 0.73 (2022), against an average of 0.5.
- The largest annual shift saw Equity Ratio grew 0.16% in 2023 before it tumbled 91.97% in 2024.
- A 3-year view of Equity Ratio shows it stood at 0.73 in 2022, then increased by 0.16% to 0.73 in 2023, then crashed by 91.97% to 0.06 in 2024.
- Per Business Quant, the three most recent readings for ZJYL's Equity Ratio are 0.06 (Q3 2024), 0.73 (Q3 2023), and 0.73 (Q3 2022).